BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6159665)

  • 1. [Porphyria cutanea tarda caused by long-term use of femigen].
    Chowaniec O; Wierzbieta J
    Przegl Dermatol; 1980; 67(3):349-52. PubMed ID: 6159665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Incidence of arterial hypertension in women taking oral hormonal contraceptive agents (femigen)].
    Mikrut W
    Wiad Lek; 1983 Oct; 36(19):1587-92. PubMed ID: 6198806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of femigen used as a contraceptive on female sexuality].
    Mikrut W
    Wiad Lek; 1982 Jun; 35(10):627-34. PubMed ID: 6182698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sequenz-Ovosiston as a contraceptive agent].
    Zwahr C
    Zentralbl Gynakol; 1972 Dec; 94(49):1722-5. PubMed ID: 4119508
    [No Abstract]   [Full Text] [Related]  

  • 5. [Contraceptives, application and side effects from the dermatological viewpoint].
    Schäfer I
    Dtsch Gesundheitsw; 1971 Feb; 26(9):405-9. PubMed ID: 4104204
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug-induced liver damage following use of the oral contraceptive Femigen].
    Kwaśniewska W; Raczyńska A
    Patol Pol; 1974; 25(1):101-6. PubMed ID: 4133325
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral contraceptives and porphyria cutanea tarda.
    Behm AR; Unger WP
    Can Med Assoc J; 1974 May; 110(9):1052-4. PubMed ID: 4823112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified sequential oral contraception employing mestranol with chlormadinone.
    Tyler ET; Matsner EM; Gotlib M
    Obstet Gynecol; 1969 Dec; 34(6):820-4. PubMed ID: 4189147
    [No Abstract]   [Full Text] [Related]  

  • 9. [Possible side effect of hormonal contraception: porphyria cutanea tarda].
    Zaumseil RP; Fiedler H
    Zentralbl Gynakol; 1983; 105(8):527-31. PubMed ID: 6868877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cases of neuro-ophthalmological complications after the use of oral contraceptive agents].
    Debicka A; Nitoń A
    Klin Oczna; 1982; 84(5-6):171-2. PubMed ID: 6185720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Porphyria cutanea tarda after prolonged taking of oral contraceptives].
    Degos R; Touraine R; Kalis B; Delort J; Bonvalet D
    Ann Dermatol Syphiligr (Paris); 1969; 96(1):5-14. PubMed ID: 5367491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Porphyria cutanea tarda and the pill: case report.
    Austad WI; Hamilton-Gibbs JS
    N Z Med J; 1975 Jan; 81(531):8-10. PubMed ID: 1055316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A modified sequential contraceptive.
    Rice-Wray E; Gorodovsky J; Peña A
    Contraception; 1972 Jun; 5(6):457-72. PubMed ID: 4119579
    [No Abstract]   [Full Text] [Related]  

  • 14. [A case of extensive myocardial infarction in a young woman as a complication of oral contraceptives and alcohol].
    Poniecki A; Peterson-Mroczek S; Hrynkiewicz Z
    Pol Tyg Lek; 1988 Feb; 43(8):256-8. PubMed ID: 2457208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A gradual method for a more physiological hormonal contraception].
    Hamann B; Büchner C
    Zentralbl Gynakol; 1976; 98(23):1445-9. PubMed ID: 65068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of an oral contraceptive Femigen-Polfa by epileptic women].
    Rościszewska D
    Neurol Neurochir Pol; 1973; 7(5):715-7. PubMed ID: 4128492
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experiences with Ovosiston in a new dosage form].
    Zwahr C
    Dtsch Gesundheitsw; 1970 Apr; 25(14):635-9. PubMed ID: 4098545
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experiences with different doses of Ovosiston preparations within the scope of marital and sexual counseling. Individual therapy with oral contraceptives].
    Ebeling K; Kühndel K; Rothe K
    Dtsch Gesundheitsw; 1971 Jan; 26(1):31-4. PubMed ID: 4106517
    [No Abstract]   [Full Text] [Related]  

  • 19. [Porphyria cutanea praematura caused by hormonal contraceptives].
    Doss M
    Dtsch Med Wochenschr; 1977 Jun; 102(23):875-7. PubMed ID: 872749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nonanouvlatory doses of sequential mestranol-chlormadinone combination in female acne].
    Romiti N
    An Bras Dermatol; 1971; 46(1):13-8. PubMed ID: 4108151
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.